Revenue (TTM) Chart

View Revenue (TTM) for A.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue (TTM) Chart
Start Trial

Historical Revenue (TTM) Data

View and export this data back to 2000. Start Trial.
Date Value
July 31, 2026 7.372B
April 30, 2026 7.232B
January 31, 2026 7.065B
October 31, 2025 6.948B
July 31, 2025 6.788B
April 30, 2025 6.628B
January 31, 2025 6.533B
October 31, 2024 6.51B
July 31, 2024 6.497B
April 30, 2024 6.591B
January 31, 2024 6.735B
October 31, 2023 6.833B
July 31, 2023 6.994B
April 30, 2023 7.04B
January 31, 2023 6.93B
October 31, 2022 6.848B
July 31, 2022 6.659B
April 30, 2022 6.527B
January 31, 2022 6.445B
October 31, 2021 6.319B
July 31, 2021 6.142B
April 30, 2021 5.817B
January 31, 2021 5.53B
October 31, 2020 5.339B
July 31, 2020 5.223B
Date Value
April 30, 2020 5.236B
January 31, 2020 5.236B
October 31, 2019 5.163B
July 31, 2019 5.09B
April 30, 2019 5.019B
January 31, 2019 4.987B
October 31, 2018 4.914B
July 31, 2018 4.809B
April 30, 2018 4.72B
January 31, 2018 4.616B
October 31, 2017 4.472B
July 31, 2017 4.394B
April 30, 2017 4.324B
January 31, 2017 4.241B
October 31, 2016 4.202B
July 31, 2016 4.126B
April 30, 2016 4.096B
January 31, 2016 4.04B
October 31, 2015 4.038B
July 31, 2015 4.046B
April 30, 2015 4.041B
January 31, 2015 4.809B
October 31, 2014 5.462B
July 31, 2014 6.137B
April 30, 2014 6.78B

Revenues Definition

Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.

Read full definition.

Revenue (TTM) Range, Past 5 Years

View Revenue (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue (TTM) Benchmarks

View Revenue (TTM) Benchmarks
Start Trial
Danaher Corp. 25.11B
Thermo Fisher Scientific, Inc. 46.34B
Waters Corp. 4.644B
Illumina, Inc. 4.495B
Revvity, Inc. 2.912B